Understanding Prostate Cancer Screening through the Stockholm3 Blood Test

A simple blood test for early detection of aggressive prostate cancer.

• No GP referral
• Results within 14 working days
• Detailed risk score report

What is Prostate Cancer Screening?

Prostate cancer screening is a crucial process that helps identify the presence of cancer in men’s prostates at an early stage. The Stockholm3 test is an innovative blood test designed specifically for this purpose. It analyses various biomarkers, along with clinical data, to assess the risk of prostate cancer. By detecting possible cancer early, we can monitor and manage the condition more effectively, which is beneficial, especially for high-risk individuals.

How Does the Stockholm3 Test Work?

The Stockholm3 test combines genetic information and other biological markers to provide a comprehensive risk assessment. This test offers a multifaceted view and tests more than PSA blood tests. It looks at various genes and their expressions, allowing doctors to give a more accurate prognosis. Therefore, this enhanced approach results in fewer unnecessary biopsies, making the testing process aim for better patient outcomes.

Benefits of the Stockholm3 Test

One significant advantage of the Stockholm3 prostate cancer screening blood test is its ability to reduce the number of invasive procedures. Many men worry about the side effects of traditional testing methods, and the Stockholm3 test is less invasive and more patient-friendly. It also leads to fewer false positives, providing peace of mind for patients. It provides better accuracy, ensuring that all men receive appropriate care at the right time.